Keyphrases
Overexpression
100%
Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
100%
SLC5A2
100%
Philadelphia Chromosome
42%
B-cell Acute Lymphoblastic Leukemia (B-ALL)
35%
Disease Status
21%
Fructose
21%
Tyrosine Kinase Inhibitor
21%
Minimal Residue Disease
21%
Microarray Analysis
14%
Gene Expression
7%
Recurrent Disease
7%
Tumor Cells
7%
Mechanistic Studies
7%
Clinical Factors
7%
Expression Suppression
7%
Protein Level
7%
MRNA Level
7%
Drug-induced
7%
Glycolysis
7%
Cytotoxicity
7%
Gene Expression Profile
7%
Leukemia Therapy
7%
Induced Cell Death
7%
Cell Uptake
7%
Validation Cohort
7%
Complete Remission
7%
Dasatinib
7%
Imatinib
7%
Early Relapse
7%
Tyrosine Kinase Inhibitor Treatment
7%
GLUT5
7%
Leukaemia Clinical
7%
ABL1 Kinase
7%
Nutrition Deficiency
7%
Member 5
7%
Glycogenesis
7%
Fructose Uptake
7%
Solute Carrier Family
7%
BCR-ABL1
7%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Philadelphia 1 Chromosome
100%
Acute B-Cell Lymphoblastic Leukemia
71%
Tyrosine-Kinase Inhibitor
57%
Fructose
57%
Disease
42%
Gene Expression
28%
Recurrent Disease
14%
Cell Line
14%
Cytotoxicity
14%
Tumor Cell
14%
Cell Death
14%
Phosphotransferase
14%
Nutritional Deficiency
14%
Glycogen Synthesis
14%
Dasatinib
14%
Imatinib
14%
Sodium Glucose Cotransporter 2
14%
Glucose Transporter 5
14%
Biochemistry, Genetics and Molecular Biology
Philadelphia Chromosome
100%
B Cell
71%
Fructose
57%
Tyrosine Kinase Inhibitor
57%
Gene Expression
28%
Microarrays
28%
Messenger RNA
14%
Phosphotransferase
14%
Cell Death
14%
Cytotoxicity
14%
Kinase
14%
Glycogenesis
14%
Imatinib
14%
Solute Carrier Family
14%
GLUT5
14%
Dasatinib
14%
Immunology and Microbiology
Philadelphia 1 Chromosome
100%
B Cell
71%
Gene Expression
28%
Cell Line
14%
Tumor Cell
14%
Cell Death
14%
Cytotoxicity
14%
Glycogen Synthesis
14%